Lori B Croft, MD

Clinical Focus

• Coronary Artery Disease
• Echocardiography
• Heart Disease
• Transesophageal echocardiography
• Valvular Heart Disease

• Coronary Artery Disease
• Echocardiography
• Heart Disease
• Transesophageal echocardiography
• Valvular Heart Disease

Locations

Mount Sinai Cardiovascular Institute

1190 Fifth Avenue, 1st Floor, New York, NY, 10029

212-427-1540

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:20

Review Article:4

Letter:1

Editorial:1

Recent Artifacts

• Obstructive sleep apnoea and left ventricular diastolic dysfunction among first responders to the 9/11 World Trade Center terrorist attack: A cross-sectional study
• Assessment and validation of a novel fast fully automated artificial intelligence left ventricular ejection fraction quantification software
• Using Clinical and Echocardiographic Characteristics to Characterize the Risk of Ischemic Stroke in Patients with COVID-19
• Echocardiography in the time of Covid-19: Ultrasound enhancing agents save time and augment diagnostic information
• Functional Effects of Cardiomyocyte Injury in COVID-19
• HIF-1α Cardioprotection in COVID-19 Patients
• Abnormal left ventricular global longitudinal strain by speckle tracking echocardiography in COVID-19 patients
• Biventricular strain by speckle tracking echocardiography in COVID-19: Findings and possible prognostic implications
• Transcatheter embolic coils to treat peridevice leaks after left atrial appendage closure
• Multimodality cardiac imaging for management of a cardiac mass in the era of COVID-19: A case report

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Croft did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.